China-based CGM developer Sinocare recently announced a significant legal victory over Abbott, a market leader in the CGM space. Our sister site, Drug Delivery Business News, reports that a judge in the High Court of Justice (Chancery Division) of England and Wales rejected claims of trademark infringement and passing off made by Abbott against Sinocare. According […]
Diabetes
Welcome to MassDevice's Diabetes Hub, your resource for the latest news in diabetes technology. Stay informed about the innovations and business news shaping the diabetes device industry.
Here are top diabetes features from MassDevice and its sister publications (and scroll down to read the latest diabetes device news from MassDevice):
+ The 9 largest diabetes tech companies in the world
+ These diabetes devices are set to launch in 2024
+ The biggest stories from the American Diabetes Association (ADA) 2024 Scientific Sessions
+ These diabetes devices are set to launch in 2024
+ How Dexcom designed a new “life-changing” sensor for even more people with diabetes
+ Embecta CEO sees GLP-1 opportunities as company progresses on insulin patch pump
Latest Diabetes News
Senseonics submits year-long CGM for CE mark
Senseonics (NYSE:SENS) today announced a step toward bringing its 365-day continuous glucose monitor to a new geography. Our sister site, Drug Delivery Business News, reports today that the company submitted its Eversense 365 system for CE mark. Eversense 365, the world’s first 365-day CGM system, is the only CGM offering a year-long wear time. Market-leading, non-implanted […]
FDA warns of potential missed alerts with smartphone-connected diabetes devices
The FDA today issued a safety communication relating to certain diabetes devices that connect to smartphones. Our sister site, Drug Delivery Business News, reports today that the FDA received medical device reports in which users reported failed delivery of alerts or failure to hear alerts from their smartphones that connect to diabetes devices. In these cases, […]
Abbott launches initiative to combat diabetes stigma
Abbott (NYSE:ABT) is launching a new initiative that takes a look at some of the stigmas and stereotypes that come with managing diabetes. Our sister site, Drug Delivery Business News, reports today that the maker of the leading FreeStyle Libre continuous glucose monitor (CGM) platform launched the “Above the Bias” initiative after a new survey highlighted how […]
Glucotrack completes first-in-human continuous blood glucose monitor implant study
Glucotrack (Nasdaq:GCTK) today said it hit a significant milestone in the development of its continuous blood glucose monitor (CBGM). Our sister site, Drug Delivery Business News, reports today that Glucotrack completed the first-in-human study of its CBGM. Unlike traditional CGMs that measure glucose in interstitial fluid, the CBGM measures glucose levels directly from the blood. It […]
Fractyl Health announces layoffs as it pivots to gene therapy
Fractyl Health (Nasdaq:GUTS) wants to focus more on certain therapies, leading the company to cut nearly a fifth of its entire workforce. Our sister site, Drug Delivery Business News, reports today that Fractyl plans to pause investment in its Revita programs for type 2 diabetes to extend its cash runway through 2026. Revita, a diabetes reversal […]
Beta Bionics goes public with upsized $204M IPO
Beta Bionics (Nasdaq:BBNX) has gone public after pricing a significantly upsized initial public offering (IPO). Our sibling site Drug Delivery Business News reported the news today, which is Beta Bionics’ first day of trading. Earlier this month, the company filed a registration statement with the SEC relating to a proposed IPO. Beta Bionics, maker of the […]
Dexcom CEO says 2025 is ‘shaping up to be a good year’ with Stelo launch, GenAI integration
After a busy 2024, Dexcom (Nasdaq:DXCM) Chair and CEO Kevin Sayer believes the company is set for more milestones in 2025. Our sister site, Drug Delivery Business News, spoke with Sayer recently about the developments at the company over the last 12 months, as well as what may come in the next 12 months and beyond. […]
Beta Bionics to raise $114.4M in IPO
Beta Bionics today provided more details related to its plans to raise funds through an initial public offering (IPO). Earlier this month, the maker of the iLet bionic pancreas filed a registration statement with the SEC relating to a proposed IPO. Our sister site, Drug Delivery Business News reports today that the company filed a prospectus […]
Abbott sales come up just shy of Q4 expectations on Wall Street, highlights EP growth
Abbott reported fourth-quarter results that missed the consensus sales forecast — but medical device sales remain a bright spot. Shares of ABT dipped 2.1% to $114.31 apiece in pre-market trading today. However, they rose 0.6% to $117.47 after the market opened. The Abbott Park, Illinois–based company reported profits of $9.2 billion for the quarter. That […]
Medtronic says it has next-gen insulin pumps on the way, more to come from diabetes business
Medtronic officials at the JP Morgan Healthcare Conference have outlined some potentially exciting developments within the Diabetes business. Our sister site, Drug Delivery Business News, reports today that CEO Geoff Martha and Que Dallara, EVP and president of Medtronic Diabetes, spoke at the conference about future plans and next-generation technologies. Among the topics covered were […]